Impact of the first lockdown for coronavirus 19 on breast cancer management in France: A multicentre survey.
J Gynecol Obstet Hum Reprod
; 50(9): 102166, 2021 Nov.
Article
in English
| MEDLINE | ID: covidwho-1240456
ABSTRACT
OBJECTIVE:
This study examined the impact of lockdown for SARS-CoV-2 on breast cancer management via an online survey in a French multicentre setting. MATERIAL ANDMETHODS:
This is a multicentre retrospective study, over the strict lockdown period from March 16th to May 11th, 2020 in metropolitan France. 20 centres were solicited, of which 12 responded to the survey.RESULTS:
50% of the centres increased their surgical activity, 33% decreased it and 17% did not change it during containment. Some centres had to cancel (17%) or postpone (33%) patient-requested interventions due to fear of SARS-CoV-2. Four and 6 centres (33% and 50%) respectively cancelled and postponed interventions for medical reasons. In the usual period, 83% of the centres perform their conservative surgeries on an outpatient basis, otherwise the length of hospital stay was 24 to 48 h. All the centres except one performed conservative surgery on an outpatient basis during the lockdown period, for which. 8% performed mastectomies on an outpatient basis during the usual period. During lockdown, 50% of the centres reduced their hospitalization duration (25% outpatient /25% early discharge on Day 1).CONCLUSION:
This study explored possibilities for management during the first pandemic lockdown. The COVID-19 pandemic required a total reorganization of the healthcare system, including the care pathways for cancer patients.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Surgical Procedures, Operative
/
Breast Neoplasms
/
SARS-CoV-2
/
COVID-19
Type of study:
Experimental Studies
/
Observational study
/
Randomized controlled trials
Limits:
Female
/
Humans
Country/Region as subject:
Europa
Language:
English
Journal:
J Gynecol Obstet Hum Reprod
Year:
2021
Document Type:
Article
Affiliation country:
J.jogoh.2021.102166
Similar
MEDLINE
...
LILACS
LIS